Ladophar proposes capital raise, new business lines to tackle losses

Lam Dong Pharmaceutical JSC (Ladophar) has announced an Extraordinary General Meeting (EGM) in December 2025 to discuss key strategic initiatives. The company plans to increase its charter capital to VND 280,922,340,000, up from the current VND 187,281,670,000. This increase will be achieved through a private placement to existing shareholders, offering up to 9,364,067 new shares at VND 10,000 per share with a 2:1 ratio.

The EGM will also address accumulated losses. The Board proposes using VND 24,348,384,362 from the development investment fund and VND 5,390,000,000 from share premium to offset a portion of the VND 50,655,818,563 in accumulated losses as of June 30, 2025. Additionally, Ladophar seeks to expand its business activities by adding new sectors, including retail of alcoholic and non-alcoholic beverages in specialized stores, and diversifying its borrowing methods to include individuals and other organizations.

The company recently completed an ESOP share issuance of 635,000 shares, raising VND 6,350,000,000. It also confirmed the completion of a private placement of 5,390,000 shares to APC Holdings at VND 11,000 per share, generating VND 59,290,000,000. These funds are earmarked for the CO2 super-critical factory project and working capital.